Skip to content

Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients

Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients: Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02856932
Enrollment
31
Registered
2016-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2016-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Class I Cavities in High Caries Risk

Brief summary

PICOTS: P: High Caries Risk Patients with bilateral class I cavities. I: Glass Ionomer with Glass Hybrid Technology. C: Conventional High Viscosity Glass Ionomer. O: Clinical performance (Functional properties Biological properties) using (World Dental Federation) Fédération dentaire internationale (FDI) criteria for dental restorations. T: 1 year. S: Randomized controlled Trial (split mouth design). Research question:In high caries risk patients with class I cavities will glass ionomer with glass hybrid technology has similar clinical performance as conventional high viscosity glass ionomer

Interventions

OTHERConventional high viscosity glass ionomer

Dental restorative material

OTHERGlass ionomer with glass hybrid technology

Dental restorative material

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 50 Years

Inclusion criteria

* Bilateral class I carious lesions in their occlusal pits and fissures. * High caries risk patients who has 1 or more cavitated lesion with risk factor declared by Caries Management By Risk Assessment (CAMBRA) * Co-operative patients approving to participate in the trial.

Exclusion criteria

* Disabilities. * Systemic diseases or severe medically compromised. * Lack of compliance. * Evidence of severe bruxism, clenching or temporomandibular joint disorders

Design outcomes

Primary

MeasureTime frame
Clinical performance using FDI criteria for dental restorations (functional properties and biological properties)1 year

Countries

Egypt

Contacts

Primary ContactMohamed R El-Bialy, Assistant lecturer
M.refaat.op@gmail.com+201202552666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026